CADENCE PHARMACEUTICALS INC — key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2013)

$112.6M

Net Income/Loss (FY2013)

-$24.3M

Total Assets (FY2013)

$90.8M

Total Equity (FY2013)

$34.9M

Cash Flows from Operating Activities (FY2013)

-$23.2M

Source: CADENCE PHARMACEUTICALS INC 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.